Health Catalyst, Inc.

DB:2YP Stock Report

Market Cap: €413.5m

Health Catalyst Management

Management criteria checks 3/4

Health Catalyst's CEO is Dan Burton, appointed in Oct 2012, has a tenure of 12.17 years. directly owns 1.53% of the company’s shares, worth €6.32M. The average tenure of the management team and the board of directors is 2.3 years and 6.3 years respectively.

Key information

Dan Burton

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure12.2yrs
CEO ownership1.5%
Management average tenure2.3yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dan Burton's remuneration changed compared to Health Catalyst's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$79m

Jun 30 2024n/an/a

-US$86m

Mar 31 2024n/an/a

-US$106m

Dec 31 2023n/an/a

-US$118m

Sep 30 2023n/an/a

-US$124m

Jun 30 2023n/an/a

-US$147m

Mar 31 2023n/an/a

-US$148m

Dec 31 2022US$4mUS$150k

-US$137m

Sep 30 2022n/an/a

-US$151m

Jun 30 2022n/an/a

-US$145m

Mar 31 2022n/an/a

-US$147m

Dec 31 2021US$6mUS$300k

-US$153m

Sep 30 2021n/an/a

-US$147m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$126m

Dec 31 2020US$5mUS$315k

-US$115m

Sep 30 2020n/an/a

-US$86m

Jun 30 2020n/an/a

-US$99m

Mar 31 2020n/an/a

-US$181m

Dec 31 2019US$4mUS$350k

-US$241m

Sep 30 2019n/an/a

-US$304m

Jun 30 2019n/an/a

-US$282m

Mar 31 2019n/an/a

-US$190m

Dec 31 2018US$5mUS$315k

-US$114m

Compensation vs Market: Insufficient data to establish whether Dan's total compensation is reasonable compared to companies of similar size in the German market.

Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.

CEO

Dan Burton (49 yo)

12.2yrs

Tenure

Mr. Daniel D. Burton, also known as Dan, has been the Chief Executive Officer of Health Catalyst, Inc. since October 2012 and has been its Director since September 2011. Mr. Burton has strategy and leaders...

Leadership Team

NamePositionTenureCompensationOwnership
Daniel Burton
CEO & Director12.2yrsno data1.53%
€ 6.3m
Jason Alger
Chief Financial Officerless than a yearUS$823.62k0.14%
€ 589.2k
Benjamin Landry
General Counsel & Secretary of the Board1.6yrsUS$946.31k0.12%
€ 490.9k
Linda Llewelyn
Chief People Officer6.8yrsUS$1.06m0.048%
€ 197.8k
Daniel LeSueur
Chief Operating Officerless than a yearno data0.039%
€ 161.2k
Dave Ross
Chief Technology Officer2.3yrsno datano data
Adam Brown
Senior Vice President of Investor Relations and Financial Planning & Analysis3.9yrsno datano data
Amanda Flanders
Senior Vice President of Marketing & Communicationsless than a yearno datano data
Kyle Salyers
Chief Strategy Officer & Senior VP of Corporate Developmentno datano datano data
Jeffrey Selander
Senior Vice President of International5.6yrsno datano data
Holly Rimmasch
Senior VP & Chief Clinical Officerno datano datano data
Leslie Falk
Chief Client Success Officerno datano datano data

2.3yrs

Average Tenure

46yo

Average Age

Experienced Management: 2YP's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Daniel Burton
CEO & Director13.3yrsno data1.53%
€ 6.3m
John Kane
Independent Chairman8.8yrsUS$316.16k0.18%
€ 748.7k
Julie Larson-Green
Independent Director4.9yrsUS$233.49k0.079%
€ 326.1k
S. Smith
Independent Director4.9yrsUS$237.25k0.073%
€ 303.4k
Anita Pramoda
Independent Director8.7yrsUS$244.77k0.061%
€ 253.8k
Duncan Gallagher
Independent Director7.6yrsUS$244.77k0.096%
€ 395.0k
Jill Green
Directorno datano datano data
Matthew Kolb
Independent Director1.4yrsno datano data

6.3yrs

Average Tenure

60yo

Average Age

Experienced Board: 2YP's board of directors are considered experienced (6.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 09:59
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Health Catalyst, Inc. is covered by 22 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhilin LongBerenberg
David LarsenBTIG
Richard CloseCanaccord Genuity